Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America. The company offers treatment services, including radiotherapy, hormone therapy, immunotherapy, target therapy, breast cancer hormone therapy, chemotherapy, oral chemotherapy, prostate cancer hormone therapy, palliative care, port-a-cath, bone marrow transplant, and non-oncological infusions; and surgery procedures, such as breast, head and neck, lung, stomach, oncological, gynecological, prostate cancer, bladder cancer, kidney cancer, and testicular cancer. It also provides diagnostics comprising pathological analysis, genetic testing, molecular journey, personalized medicine and individualized treatment, myelogram-bone marrow biopsy, and ONCO test-PDO. In addition, it offers treatment support services, which include veinviewer, cryotherapy, integrative medicine, and DeLife, as well as hilotherapy, laser therapy, OC care line, OC precision medicine, OncoACCESS, survivorship, and telemedicine. Oncoclínicas do Brasil Serviços Médicos S.A. was founded in 2010 and is headquartered in São Paulo, Brazil.
Metrics to compare | ONCO3 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipONCO3PeersSector | |
---|---|---|---|---|
P/E Ratio | −1.5x | 3.6x | −0.7x | |
PEG Ratio | 0.00 | 0.16 | 0.00 | |
Price/Book | 0.5x | 0.7x | 2.6x | |
Price / LTM Sales | 0.2x | 0.6x | 3.4x | |
Upside (Analyst Target) | 33.3% | 21.2% | 37.6% | |
Fair Value Upside | Unlock | 40.9% | 5.3% | Unlock |